Novo Nordisk
NVO
#74
Rank
โ‚น19.229 T
Marketcap
โ‚น4,328
Share price
3.92%
Change (1 day)
-53.34%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.797 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.21 Billion. In 2024 the company made an earning of โ‚น1.700 Trillion, an increase over its 2023 earnings that were of โ‚น1.384 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น1.797 T5.71%
2024 โ‚น1.700 T22.84%
2023 โ‚น1.384 T57.81%
2022 โ‚น877.02 B5.24%
2021 โ‚น833.39 B12.38%
2020 โ‚น741.57 B13.11%
2019 โ‚น655.62 B-3.45%
2018 โ‚น679.05 B1.88%
2017 โ‚น666.49 B4.3%
2016 โ‚น639.00 B10.32%
2015 โ‚น579.21 B7.47%
2014 โ‚น538.97 B3.4%
2013 โ‚น521.24 B19.09%
2012 โ‚น437.70 B15.58%
2011 โ‚น378.70 B16.58%
2010 โ‚น324.85 B25.66%
2009 โ‚น258.52 B10.68%
2008 โ‚น233.58 B55.82%
2007 โ‚น149.91 B7.02%
2006 โ‚น140.07 B19.05%
2005 โ‚น117.65 B10.55%
2004 โ‚น106.42 B
2002 โ‚น73.06 B-14.39%
2001 โ‚น85.34 B-52.82%
2000 โ‚น180.87 B250%
1999 โ‚น51.67 B31.21%
1998 โ‚น39.38 B34.31%
1997 โ‚น29.32 B11.46%
1996 โ‚น26.30 B9.03%
1995 โ‚น24.12 B-3.15%
1994 โ‚น24.91 B-0.67%
1993 โ‚น25.08 B45.38%
1992 โ‚น17.25 B-13.81%
1991 โ‚น20.01 B37.12%
1990 โ‚น14.59 B-0.79%
1989 โ‚น14.71 B26.2%
1988 โ‚น11.65 B24.97%
1987 โ‚น9.32 B-0.9%
1986 โ‚น9.41 B-7.78%
1985 โ‚น10.20 B24.87%
1984 โ‚น8.17 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.064 T-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.021 T 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น721.61 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น817.48 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France